Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. [electronic resource]
Producer: 20200219Description: 4562 p. digitalISSN:- 2041-1723
- Antineoplastic Agents -- pharmacology
- Carcinogenesis -- drug effects
- Cell Line, Tumor
- Datasets as Topic
- Drug Screening Assays, Antitumor
- Enhancer Elements, Genetic -- genetics
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Regulatory Networks -- drug effects
- Genomics
- Humans
- Inhibitory Concentration 50
- Molecular Targeted Therapy -- methods
- Neoplasms -- genetics
- Oncogene Proteins -- genetics
- Promoter Regions, Genetic
- RNA, Untranslated -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Transcription Factors -- genetics
- Transcription, Genetic -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.